Advisory Council on Rare Diseases and Personalized Medicine (RDAC)

Meeting information is retained on this page for 7 years then sent to the Missouri State Archives.

Register for Public Comment

Any interested party shall be granted the opportunity for clinically relevant public comment for up to three (3) minutes per medication under review by the RDAC. The responsibility of scheduling the presentation shall rest with the interested party, and registration must be completed prior to the scheduled meeting. Interested parties representing a manufacturer shall be granted three (3) minutes in the aggregate per medication under review by the RDAC.